Sage are leaders in the provision of transactional and strategic advice to companies in the healthcare and life science sectors.
Sage is a global healthcare transaction advisory firm focused exclusively on life sciences. We work with pharmaceutical, biotechnology, medical technology, diagnostics and advanced therapy companies to execute licensing, partnering, M&A and strategic transactions.
Our principals have led more than 200 multinational transactions across the United States, Europe, Japan, China, Australia, the Middle East and Latin America, covering assets from early clinical stage through to global commercial products.
Unlike generalist investment banks or consulting firms, Sage operates as a highly specialised transaction platform. We combine deep sector expertise, direct access to corporate decision-makers, and proprietary AI-driven analytics to identify, qualify and close the right transactions for our clients.
Sage maintains offices and affiliated teams across North America, Europe, Israel and Asia-Pacific, allowing us to operate continuously across time zones and cultures and to engage decision-makers in their local markets.
Sector Focus
We work exclusively with healthcare-focused organizations across a broad range of bio-industry segments, including:
Pharmaceuticals
Biotechnology
Cell and Gene Therapy
Diagnostics and Digital Biomarkers
Medical Devices and Medical Technology
Regenerative Medicine
Analytical Instrumentation
Veterinary Health
AI-enabled Drug Discovery and Tech-Bio Platforms
We have incredible industry Longevity and Credibility
30 years of guiding life sciences deals through every market cycle. Sage is battle-tested in volatile times.
Why clients choose Sage
Because in life sciences, who you speak to matters as much as what you own. We bring our clients directly to the global decision-makers who control:
R&D strategy
Acquisition pipelines
Licensing budgets
Portfolio prioritisation
And we manage the entire process — from narrative and valuation through negotiation and closing — to protect value and maximise leverage.
Sage Healthcare combines senior-level transaction execution, global life-science deal experience and structured partner targeting to help companies identify, approach and negotiate with the right counterparties.
Sage’s value is particularly relevant where a company needs to…
determine whether an asset is transaction-ready
sharpen positioning for strategic partners
identify a broader and more relevant global target universe
move beyond informal BD conversations
create competitive tension
manage a disciplined partnering or M&A process
support negotiations through to term sheet and closing
align board, management and investors around a practical transaction route
